tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ANRO Stock Latest News

RatingsPromising Pipeline and Expert Backing Drive Buy Rating for Alto Neuroscience, Inc.
3d ago
ANRO
PremiumRatings
Alto Neuroscience: Strategic Pipeline Expansion and Strong Financial Position Justify Buy Rating
6d ago
ANRO
PremiumRatings
Alto Neuroscience, Inc.: Promising Pipeline and Financial Stability Justify Buy Rating
9d ago
ANRO
PremiumCompany Announcements
Alto Neuroscience Advances Pipeline Amidst Strong Cash Position
10d ago
ANRO
PremiumCompany Announcements
Alto Neuroscience Appoints Dr. Sanchez to Board
10d ago
8K
ANRO
PremiumClass ActionAlto Neuroscience Faces Legal Storm Over Drug Claims
24d ago
ANRO
Alto Neuroscience highlights study results guiding ALTO-207 development
Premium
The Fly
Alto Neuroscience highlights study results guiding ALTO-207 development
2M ago
ANRO
Premium
Ratings
Optimistic Buy Rating for Alto Neuroscience Amid Promising ALTO-203 Developments and Strategic Opportunities
2M ago
ANRO
PremiumRatings
Promising Phase 2 Results for ALTO-203 in Treating Anhedonia-MDD Justify Buy Rating
2M ago
ANRO
Alto Neuroscience identifies biomarker, reports ALTO-203 pharmacodynamic results
PremiumThe Fly
Alto Neuroscience identifies biomarker, reports ALTO-203 pharmacodynamic results
2M ago
ANRO
PremiumCompany Announcements
Alto Neuroscience Reports Positive Phase 2 Trial Results
2M ago
8K
ANRO
PremiumRatings
Promising Future for Alto Neuroscience: Strategic Acquisition and Strong Financial Position Drive Buy Rating
2M ago
ANRO
PremiumRatingsBuy Rating for Alto Neuroscience Driven by Strategic Acquisitions and Promising Pipeline Developments
3M ago
ANRO
Premium
Ratings
Alto Neuroscience’s Strategic Acquisition and Promising Pipeline Boost Buy Rating
3M ago
ANRO
Premium
Ratings
Strategic Acquisition and Promising Clinical Developments Drive Buy Rating for Alto Neuroscience, Inc.
3M ago
ANRO
PremiumCompany Announcements
Alto Neuroscience Acquires Assets from Chase Therapeutics
3M ago
8K
ANRO
Alto Neuroscience acquires dopamine agonist combination candidate
PremiumThe Fly
Alto Neuroscience acquires dopamine agonist combination candidate
3M ago
ANRO
PremiumRatings
Alto Neuroscience, Inc.: Promising Clinical Trials and Strong Financial Position Justify Buy Rating
3M ago
ANRO
PremiumCompany Announcements
Alto Neuroscience Advances Precision Psychiatry Pipeline
3M ago
ANRO
PremiumRatingsAlto Neuroscience, Inc.: Buy Rating Affirmed on Strong Financial Outlook and Promising Clinical Trials
3M ago
ANRO
Premium
Ratings
Promising Future for Alto Neuroscience: Strong Pipeline and Financial Stability Drive Buy Rating
3M ago
ANRO
Premium
Company Announcements
Alto Neuroscience Approves Key Proposals at Annual Meeting
3M ago
8K
ANRO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >